Human fetal liver cells for regulated ex vivo erythropoietin gene therapy
Possible risks and lack of donor livers limit application of liver transplantation. Liver cell transplantation is, at this moment, not a feasible alternative because engraftment in the liver is poor. Furthermore, there is also shortage of cells suitable for transplantation. Fetal liver cells are abl...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2014-01-01
|
| Edice: | Molecular Therapy: Methods & Clinical Development |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2329050116300961 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|